查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
肠躁症 (IBS) 治疗市场 - 成长、未来前景、竞争分析，2023-2031 年
市场调查报告书
商品编码
1402958

肠躁症 (IBS) 治疗市场 - 成长、未来前景、竞争分析，2023-2031 年

Irritable Bowel Syndrome Treatment Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031
出版日期: | 出版商: Acute Market Reports | 英文 117 Pages | 商品交期: 最快1-2个工作天内

价格

肠躁症（IBS）治疗市场预计在2023-2031年预测期间内复合年增长率为10.5%。IBS 治疗在缓解 IBS 患者的症状方面发挥着重要作用，IBS 是一种以腹痛、腹胀和排便习惯改变为特征的胃肠道疾病。截至 2022 年，在人们对 IBS 的认识不断提高以及对有效治疗的需求的推动下，该市场将呈现稳定成长。由于对 IBS 认识的提高、治疗方案的进步以及患病率的上升，预计 IBS 市场将持续成长。治疗限制仍然是一个障碍。领先公司透过技术创新和以患者为中心的策略保持竞争优势，预计销售额从 2022 年到 2031 年将有所成长。展望 2023 年至 2031 年，随着新的治疗方案和地理扩张，市场预计将继续发展。

对IBS的认识不断提高

2022年，由于一般民众对肠躁症（IBS）的认识不断提高，肠躁症（IBS）治疗市场出现显着成长。越来越多的人认识到这些症状并寻求诊断和治疗。这种认知的提高导致了对肠躁症治疗的需求增加，而认知是关键驱动因素。预计这一趋势将在 2023 年至 2031 年期间继续成为主要驱动力。

IBS 治疗的进展

IBS 治疗的进步也推动了市场。正在引入新的药物和治疗方法，包括处方药和非处方药，以缓解肠躁症症状。这些治疗可改善个人的生活品质并提供多种选择。治疗方法的持续进步，预计将在预测期内推动市场以高复合年增长率成长。

IBS 盛行率上升

另一个重要的推动因素是IBS盛行率的上升。IBS 影响着世界上很大一部分人口，是一种常见的胃肠道疾病。由于肠躁症是一种慢性疾病，患者需要持续治疗，促进了市场的成长。IBS 的盛行率持续上升，预计 2023 年至 2031 年对治疗方案的需求将会增加。

肠躁症（IBS）治疗市场的限制因素

儘管肠躁症（IBS）治疗市场不断成长，但仍面临与治疗限制相关的限制因素。2022 年，IBS 的治疗重点是控制症状，而不是解决根本原因。缺乏明确的治疗是一个阻碍因素。这种治疗限制预计将在 2023 年至 2031 年持续存在，因此需要继续努力开发更有效的治疗方法。

按类型细分市场：IBS-D 药物主导市场

肠躁症（IBS）治疗市场依类型可分为IBS-C（以便秘型为主）及IBS-D（以腹泻型为主）。由于 IBS-D 亚型的高盛行率，到 2022 年，IBS-D 药物的销售额将最高。然而，在 2023 年至 2031 年的预测期内，IBS-C 疗法预计将显示出最高的复合年增长率，表明该亚型需要更有效的治疗方案。

按产品细分市场：Lindseth/Constella 主导市场

另一个重要的细分因素是IBS治疗产品类别，分为Xifaxan、Linzess/Constella、Viberzi、Amitiza等。2022 年，Lindseth/Constella 的销售额最高，该药物因其在症状管理方面的有效性而闻名。然而，在2023年至2031年的预测期内，Xifaxane作为解决IBS症状的有针对性的方法并在患者中越来越受欢迎，预计将表现出最高的复合年增长率。

北美仍处于世界领先地位

依地区划分，肠躁症（IBS）治疗市场呈现不同的趋势。由于成熟的医疗保健系统和对肠躁症的高度认识，北美地区在 2022 年创下了最高的销售比率。然而，由于新兴市场对 IBS 治疗的认识和获取不断增加，亚太地区预计 2023 年至 2031 年复合年增长率最高。

预测期内市场竞争将加剧

肠躁症（IBS）治疗市场包括Allergan、Takeda、AbbVie.、Takeda、Pfizer, Inc.、Abbott Laboratories、Novartis AG、AstraZeneca PLC、Ironwood Pharmaceuticals Inc.、Bausch Health Companies Inc.、GlaxoSmithKline , Plc.、Lexicon Pharmaceuticals, Inc.、Sucampo Pharmaceuticals, Inc.等。这些公司持续投资于研发，以改善 IBS 治疗并扩大其市场份额。2022年已录得可观利润，由于策略投资，预计2023年至2031年将获得高额利润。关键策略包括引入新的治疗方案、改善患者支援以及扩大我们的分销网络以覆盖更多需要 IBS 治疗的人。

本报告回答的关键问题

影响肠躁症（IBS）治疗市场成长的关键微观和宏观环境因素有哪些？

现在和预测期内，就产品领域和地区而言，主要投资领域为何？

2031 年之前的预估与市场预测

在预测期间内，哪个细分市场的复合年增长率最快？

哪个细分市场拥有较大的市场份额，为什么？

低收入和中等收入国家是否正在投资肠躁症（IBS）治疗市场？

肠躁症（IBS）治疗市场最大的区域市场是哪一个？

亚太、拉丁美洲、中东/非洲等新兴市场的市场趋势与动态如何？

推动肠躁症（IBS）治疗市场成长的主要趋势是什么？

主要竞争对手有哪些，以及他们提高在全球肠躁症 (IBS) 治疗市场中的影响力的关键策略是什么？

目录

第一章 前言

  • 报告内容
    • 报告目的
    • 目标听众
    • 主要提供产品
  • 市场细分
  • 调查方法
    • 第一阶段—二次调查
    • 第二阶段-初步调查
    • 第三阶段-专家评审
    • 先决条件
    • 采取的方法

第二章执行摘要

第三章肠躁症（IBS）治疗市场：竞争分析

  • 主要供应商的市场地位
  • 供应商采取的策略
  • 主要产业战略
  • 等级分析：2022 年与 2031 年

第四章肠躁症（IBS）治疗市场：宏观分析与市场动态

  • 介绍
  • 2021-2031年全球肠躁症（IBS）治疗市场价值
  • 市场动态
    • 市场驱动力
    • 市场製约因素
    • 主要问题
    • 主要机会
  • 促进因素和抑制因素的影响分析
  • 跷跷板分析
  • 波特的五力模型
    • 供应商实力
    • 购买力
    • 替代品的威胁
    • 新进入者的威胁
    • 竞争对手之间的竞争
  • PESTEL 分析
    • 政局
    • 金融情况
    • 技术景观
    • 法律状况
    • 社会局势

第 5 章 肠躁症 (IBS) 治疗市场：依类型 2021-2031

  • 市场概况
  • 成长/利润分析：2022 年与 2031 年
  • 市场细分
    • IBS-C型
      • Lindseth/Constella
      • Amitiza
      • 其他
    • IBS-D
      • Sifaxan
      • Vibergi
      • 其他

第 6 章 肠躁症 (IBS) 治疗市场：副产品 2021-2031

  • 市场概况
  • 成长/利润分析：2022 年与 2031 年
  • 市场细分
    • Sifaxan
    • Lindseth/Constella
    • Vibergi
    • Amitiza
    • 其他

第七章北美肠躁症（IBS）治疗市场2021-2031

  • 市场概况
  • 肠躁症 (IBS) 治疗市场：依类型 2021-2031
  • 肠躁症 (IBS) 治疗市场：依产品 2021-2031
  • 肠躁症 (IBS) 治疗市场：按地区划分 2021-2031 年
    • 北美
      • 美国
      • 加拿大
      • 其他北美

第 8 章英国与欧盟肠躁症 (IBS) 治疗市场 2021-2031

  • 市场概况
  • 肠躁症 (IBS) 治疗市场：依类型 2021-2031
  • 肠躁症 (IBS) 治疗市场：依产品 2021-2031
  • 肠躁症 (IBS) 治疗市场：按地区划分 2021-2031 年
    • 英国和欧盟
      • 英国
      • 德国
      • 西班牙
      • 意大利
      • 法国
      • 欧洲其他地区

第 9 章 2021-2031 年亚太地区肠躁症 (IBS) 治疗市场

  • 市场概况
  • 肠躁症 (IBS) 治疗市场：依类型 2021-2031
  • 肠躁症 (IBS) 治疗市场：依产品 2021-2031
  • 肠躁症 (IBS) 治疗市场：按地区划分 2021-2031 年
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 亚太其他地区

第10章拉丁美洲肠躁症（IBS）治疗市场2021-2031

  • 市场概况
  • 肠躁症 (IBS) 治疗市场：依类型 2021-2031
  • 肠躁症 (IBS) 治疗市场：依产品 2021-2031
  • 肠躁症 (IBS) 治疗市场：按地区划分 2021-2031 年
    • 拉丁美洲
      • 巴西
      • 墨西哥
      • 其他拉丁美洲地区

第十一章中东和非洲肠躁症（IBS）治疗市场2021-2031

  • 市场概况
  • 肠躁症 (IBS) 治疗市场：依类型 2021-2031
  • 肠躁症 (IBS) 治疗市场：依产品 2021-2031
  • 肠躁症 (IBS) 治疗市场：按地区划分 2021-2031 年
    • 中东/非洲
      • GCC
      • 非洲
      • 其他中东/非洲地区

第十二章公司简介

  • Allergan
  • Takeda Pharmaceutical Company
  • AbbVie.
  • Takeda Pharmaceutical Company Limited
  • Pfizer Inc.
  • Abbott Laboratories
  • Novartis AG
  • AstraZeneca PLC
  • Ironwood Pharmaceuticals Inc.
  • Bausch Health Companies Inc.
  • GlaxoSmithKline Plc.
  • Lexicon Pharmaceuticals Inc.
  • Sucampo Pharmaceuticals Inc.
  • 其他主要公司
Product Code: 140029-12-23

The irritable bowel syndrome (IBS) treatment market is expected to grow at a CAGR of 10.5% during the forecast period of 2023 to 2031. IBS treatment plays a vital role in providing relief to individuals suffering from IBS, a gastrointestinal disorder characterized by abdominal pain, bloating, and changes in bowel habits. As of 2022, the market exhibited steady growth, driven by increased awareness of IBS and the demand for effective treatments. The IBS market is poised for continued growth, driven by growing awareness of IBS, advancements in treatment options, and the rising prevalence of the condition. Treatment limitations remain a restraint. Key players are expected to maintain their competitive edge through innovation and patient-focused strategies, with revenues projected to rise from 2022 to 2031. Looking ahead to the period from 2023 to 2031, the market is expected to continue evolving with new treatment options and geographic expansion.

Growing Awareness of IBS

In 2022, the Irritable Bowel Syndrome Treatment Market witnessed significant growth due to the increasing awareness of IBS among the general population. More individuals are recognizing the symptoms and seeking diagnosis and treatment. This growing awareness led to higher demand for IBS treatments, making awareness a crucial driver. This trend is expected to continue as a key driver from 2023 to 2031.

Advancements in IBS Treatment

The market was also driven by advancements in IBS treatment options. New medications and therapies, both prescription and over-the-counter, have been introduced to provide relief from IBS symptoms. These treatments offer a range of options for individuals, improving their quality of life. As advancements in treatment continue, they are expected to drive market growth with a high CAGR during the forecast period.

Rising Prevalence of IBS

Another significant driver was the rising prevalence of IBS. The condition affects a substantial portion of the global population, making it a common gastrointestinal disorder. With IBS being a chronic condition, individuals require ongoing treatment, contributing to the market's growth. As the prevalence of IBS continues to rise, it is expected to drive demand for treatment options from 2023 to 2031.

Restraint in the Irritable Bowel Syndrome Treatment Market

Despite its growth, the Irritable Bowel Syndrome Treatment Market faces a restraint related to treatment limitations. In 2022, treatments for IBS focused on symptom management, rather than addressing the root cause of the condition. The absence of a definitive cure acted as a restraint. It is expected that this treatment limitation will continue to be a challenge from 2023 to 2031, necessitating ongoing research efforts to develop more effective treatments.

Market Segmentation by Type: IBS-D treatments Dominate the Market

The Irritable Bowel Syndrome Treatment Market can be segmented by type into IBS-C (Constipation-predominant) and IBS-D (Diarrhea-predominant). In 2022, the highest revenue was attributed to IBS-D treatments, given the high prevalence of this IBS subtype. However, during the forecast period from 2023 to 2031, IBS-C treatments are expected to exhibit the highest CAGR, indicating the need for more effective treatment options for this subtype.

Market Segmentation by Product: Linzess/Constella Dominate the Market

Another crucial segmentation factor is the product category of IBS treatments, which can be divided into Xifaxan, Linzess/Constella, Viberzi, Amitiza, and others. In 2022, the highest revenue came from Linzess/Constella, which are known for their effectiveness in symptom management. However, during the forecast period from 2023 to 2031, Xifaxan is expected to exhibit the highest CAGR, as it offers a targeted approach in addressing IBS symptoms and gaining popularity among patients.

North America Remains the Global Leader

Geographically, the Irritable Bowel Syndrome Treatment Market exhibits diverse trends. North America recorded the highest revenue percentage in 2022, driven by a well-established healthcare system and high awareness of IBS. However, the Asia-Pacific region is expected to have the highest CAGR from 2023 to 2031, as awareness and access to IBS treatments grow in emerging markets.

Market Competition to Intensify during the Forecast Period

The Irritable Bowel Syndrome Treatment Market is characterized by competition among key players, such as Allergan, Takeda Pharmaceutical Company, AbbVie., Takeda Pharmaceutical Company Limited, Pfizer, Inc., Abbott Laboratories, Novartis AG, AstraZeneca PLC, Ironwood Pharmaceuticals Inc., Bausch Health Companies Inc., GlaxoSmithKline, Plc., Lexicon Pharmaceuticals, Inc. and Sucampo Pharmaceuticals, Inc. These companies have consistently invested in research and development to improve IBS treatments and expand their market presence. In 2022, they recorded substantial revenues, and it is expected that their strategic investments will continue to yield high returns from 2023 to 2031. Key strategies include introducing new treatment options, improving patient support, and expanding distribution networks to reach more individuals in need of IBS treatment.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation ofIrritable Bowel Syndrome Treatment market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Irritable Bowel Syndrome Treatment market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Type

    • IBS-C
  • Linzess/Constella
  • Amitiza
  • Others
    • IBS-D
  • Xifaxan
  • Viberzi
  • Others

Product

    • Xifaxan
    • Linzess/Constella
    • Viberzi
    • Amitiza
    • Others

Region Segment (2021-2031; US$ Million)

North America

U.S.

Canada

Rest of North America

UK and European Union

UK

Germany

Spain

Italy

France

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East and Africa

GCC

Africa

Rest of Middle East and Africa

Key questions answered in this report:

What are the key micro and macro environmental factors that are impacting the growth of Irritable Bowel Syndrome Treatment market?

What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2031.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Irritable Bowel Syndrome Treatment market?

Which is the largest regional market for Irritable Bowel Syndrome Treatment market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Irritable Bowel Syndrome Treatment market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Irritable Bowel Syndrome Treatment market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Irritable Bowel Syndrome Treatment Market
  • 2.2. Global Irritable Bowel Syndrome Treatment Market, By Type, 2022 (US$ Million)
  • 2.3. Global Irritable Bowel Syndrome Treatment Market, By Product, 2022 (US$ Million)
  • 2.4. Global Irritable Bowel Syndrome Treatment Market, By Geography, 2022 (US$ Million)
  • 2.5. Attractive Investment Proposition by Geography, 2022

3. Irritable Bowel Syndrome Treatment Market: Competitive Analysis

  • 3.1. Market Positioning of Key Irritable Bowel Syndrome Treatment Market Vendors
  • 3.2. Strategies Adopted by Irritable Bowel Syndrome Treatment Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2022 Versus 2031

4. Irritable Bowel Syndrome Treatment Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Irritable Bowel Syndrome Treatment Market Value, 2021 - 2031, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis
  • 4.6. Porter's Five Force Model
    • 4.6.1. Supplier Power
    • 4.6.2. Buyer Power
    • 4.6.3. Threat Of Substitutes
    • 4.6.4. Threat Of New Entrants
    • 4.6.5. Competitive Rivalry
  • 4.7. PESTEL Analysis
    • 4.7.1. Political Landscape
    • 4.7.2. Economic Landscape
    • 4.7.3. Technology Landscape
    • 4.7.4. Legal Landscape
    • 4.7.5. Social Landscape

5. Irritable Bowel Syndrome Treatment Market: By Type, 2021-2031, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 5.3. Market Segmentation
    • 5.3.1. IBS-C
      • 5.3.1.1. Linzess/Constella
      • 5.3.1.2. Amitiza
      • 5.3.1.3. Others
    • 5.3.2. IBS-D
      • 5.3.2.1. Xifaxan
      • 5.3.2.2. Viberzi
      • 5.3.2.3. Others

6. Irritable Bowel Syndrome Treatment Market: By Product, 2021-2031, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 6.3. Market Segmentation
    • 6.3.1. Xifaxan
    • 6.3.2. Linzess/Constella
    • 6.3.3. Viberzi
    • 6.3.4. Amitiza
    • 6.3.5. Others

7. North America Irritable Bowel Syndrome Treatment Market, 2021-2031, USD (Million)

  • 7.1. Market Overview
  • 7.2. Irritable Bowel Syndrome Treatment Market: By Type, 2021-2031, USD (Million)
  • 7.3. Irritable Bowel Syndrome Treatment Market: By Product, 2021-2031, USD (Million)
  • 7.4.Irritable Bowel Syndrome Treatment Market: By Region, 2021-2031, USD (Million)
    • 7.4.1.North America
      • 7.4.1.1. U.S.
        • 7.4.1.1.1. Irritable Bowel Syndrome Treatment Market: By Type, 2021-2031, USD (Million)
        • 7.4.1.1.2. Irritable Bowel Syndrome Treatment Market: By Product, 2021-2031, USD (Million)
      • 7.4.1.2. Canada
        • 7.4.1.2.1. Irritable Bowel Syndrome Treatment Market: By Type, 2021-2031, USD (Million)
        • 7.4.1.2.2. Irritable Bowel Syndrome Treatment Market: By Product, 2021-2031, USD (Million)
      • 7.4.1.3. Rest of North America
        • 7.4.1.3.1. Irritable Bowel Syndrome Treatment Market: By Type, 2021-2031, USD (Million)
        • 7.4.1.3.2. Irritable Bowel Syndrome Treatment Market: By Product, 2021-2031, USD (Million)

8. UK and European Union Irritable Bowel Syndrome Treatment Market, 2021-2031, USD (Million)

  • 8.1. Market Overview
  • 8.2. Irritable Bowel Syndrome Treatment Market: By Type, 2021-2031, USD (Million)
  • 8.3. Irritable Bowel Syndrome Treatment Market: By Product, 2021-2031, USD (Million)
  • 8.4.Irritable Bowel Syndrome Treatment Market: By Region, 2021-2031, USD (Million)
    • 8.4.1.UK and European Union
      • 8.4.1.1. UK
        • 8.4.1.1.1. Irritable Bowel Syndrome Treatment Market: By Type, 2021-2031, USD (Million)
        • 8.4.1.1.2. Irritable Bowel Syndrome Treatment Market: By Product, 2021-2031, USD (Million)
      • 8.4.1.2. Germany
        • 8.4.1.2.1. Irritable Bowel Syndrome Treatment Market: By Type, 2021-2031, USD (Million)
        • 8.4.1.2.2. Irritable Bowel Syndrome Treatment Market: By Product, 2021-2031, USD (Million)
      • 8.4.1.3. Spain
        • 8.4.1.3.1. Irritable Bowel Syndrome Treatment Market: By Type, 2021-2031, USD (Million)
        • 8.4.1.3.2. Irritable Bowel Syndrome Treatment Market: By Product, 2021-2031, USD (Million)
      • 8.4.1.4. Italy
        • 8.4.1.4.1. Irritable Bowel Syndrome Treatment Market: By Type, 2021-2031, USD (Million)
        • 8.4.1.4.2. Irritable Bowel Syndrome Treatment Market: By Product, 2021-2031, USD (Million)
      • 8.4.1.5. France
        • 8.4.1.5.1. Irritable Bowel Syndrome Treatment Market: By Type, 2021-2031, USD (Million)
        • 8.4.1.5.2. Irritable Bowel Syndrome Treatment Market: By Product, 2021-2031, USD (Million)
      • 8.4.1.6. Rest of Europe
        • 8.4.1.6.1. Irritable Bowel Syndrome Treatment Market: By Type, 2021-2031, USD (Million)
        • 8.4.1.6.2. Irritable Bowel Syndrome Treatment Market: By Product, 2021-2031, USD (Million)

9. Asia Pacific Irritable Bowel Syndrome Treatment Market, 2021-2031, USD (Million)

  • 9.1. Market Overview
  • 9.2. Irritable Bowel Syndrome Treatment Market: By Type, 2021-2031, USD (Million)
  • 9.3. Irritable Bowel Syndrome Treatment Market: By Product, 2021-2031, USD (Million)
  • 9.4.Irritable Bowel Syndrome Treatment Market: By Region, 2021-2031, USD (Million)
    • 9.4.1.Asia Pacific
      • 9.4.1.1. China
        • 9.4.1.1.1. Irritable Bowel Syndrome Treatment Market: By Type, 2021-2031, USD (Million)
        • 9.4.1.1.2. Irritable Bowel Syndrome Treatment Market: By Product, 2021-2031, USD (Million)
      • 9.4.1.2. Japan
        • 9.4.1.2.1. Irritable Bowel Syndrome Treatment Market: By Type, 2021-2031, USD (Million)
        • 9.4.1.2.2. Irritable Bowel Syndrome Treatment Market: By Product, 2021-2031, USD (Million)
      • 9.4.1.3. India
        • 9.4.1.3.1. Irritable Bowel Syndrome Treatment Market: By Type, 2021-2031, USD (Million)
        • 9.4.1.3.2. Irritable Bowel Syndrome Treatment Market: By Product, 2021-2031, USD (Million)
      • 9.4.1.4. Australia
        • 9.4.1.4.1. Irritable Bowel Syndrome Treatment Market: By Type, 2021-2031, USD (Million)
        • 9.4.1.4.2. Irritable Bowel Syndrome Treatment Market: By Product, 2021-2031, USD (Million)
      • 9.4.1.5. South Korea
        • 9.4.1.5.1. Irritable Bowel Syndrome Treatment Market: By Type, 2021-2031, USD (Million)
        • 9.4.1.5.2. Irritable Bowel Syndrome Treatment Market: By Product, 2021-2031, USD (Million)
      • 9.4.1.6. Rest of Asia Pacific
        • 9.4.1.6.1. Irritable Bowel Syndrome Treatment Market: By Type, 2021-2031, USD (Million)
        • 9.4.1.6.2. Irritable Bowel Syndrome Treatment Market: By Product, 2021-2031, USD (Million)

10. Latin America Irritable Bowel Syndrome Treatment Market, 2021-2031, USD (Million)

  • 10.1. Market Overview
  • 10.2. Irritable Bowel Syndrome Treatment Market: By Type, 2021-2031, USD (Million)
  • 10.3. Irritable Bowel Syndrome Treatment Market: By Product, 2021-2031, USD (Million)
  • 10.4.Irritable Bowel Syndrome Treatment Market: By Region, 2021-2031, USD (Million)
    • 10.4.1.Latin America
      • 10.4.1.1. Brazil
        • 10.4.1.1.1. Irritable Bowel Syndrome Treatment Market: By Type, 2021-2031, USD (Million)
        • 10.4.1.1.2. Irritable Bowel Syndrome Treatment Market: By Product, 2021-2031, USD (Million)
      • 10.4.1.2. Mexico
        • 10.4.1.2.1. Irritable Bowel Syndrome Treatment Market: By Type, 2021-2031, USD (Million)
        • 10.4.1.2.2. Irritable Bowel Syndrome Treatment Market: By Product, 2021-2031, USD (Million)
      • 10.4.1.3. Rest of Latin America
        • 10.4.1.3.1. Irritable Bowel Syndrome Treatment Market: By Type, 2021-2031, USD (Million)
        • 10.4.1.3.2. Irritable Bowel Syndrome Treatment Market: By Product, 2021-2031, USD (Million)

11. Middle East and Africa Irritable Bowel Syndrome Treatment Market, 2021-2031, USD (Million)

  • 11.1. Market Overview
  • 11.2. Irritable Bowel Syndrome Treatment Market: By Type, 2021-2031, USD (Million)
  • 11.3. Irritable Bowel Syndrome Treatment Market: By Product, 2021-2031, USD (Million)
  • 11.4.Irritable Bowel Syndrome Treatment Market: By Region, 2021-2031, USD (Million)
    • 11.4.1.Middle East and Africa
      • 11.4.1.1. GCC
        • 11.4.1.1.1. Irritable Bowel Syndrome Treatment Market: By Type, 2021-2031, USD (Million)
        • 11.4.1.1.2. Irritable Bowel Syndrome Treatment Market: By Product, 2021-2031, USD (Million)
      • 11.4.1.2. Africa
        • 11.4.1.2.1. Irritable Bowel Syndrome Treatment Market: By Type, 2021-2031, USD (Million)
        • 11.4.1.2.2. Irritable Bowel Syndrome Treatment Market: By Product, 2021-2031, USD (Million)
      • 11.4.1.3. Rest of Middle East and Africa
        • 11.4.1.3.1. Irritable Bowel Syndrome Treatment Market: By Type, 2021-2031, USD (Million)
        • 11.4.1.3.2. Irritable Bowel Syndrome Treatment Market: By Product, 2021-2031, USD (Million)

12. Company Profile

  • 12.1. Allergan
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Portfolio
    • 12.1.4. Strategic Initiatives
  • 12.2. Takeda Pharmaceutical Company
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Portfolio
    • 12.2.4. Strategic Initiatives
  • 12.3. AbbVie.
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Portfolio
    • 12.3.4. Strategic Initiatives
  • 12.4. Takeda Pharmaceutical Company Limited
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Portfolio
    • 12.4.4. Strategic Initiatives
  • 12.5. Pfizer, Inc.
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Portfolio
    • 12.5.4. Strategic Initiatives
  • 12.6. Abbott Laboratories
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Portfolio
    • 12.6.4. Strategic Initiatives
  • 12.7. Novartis AG
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Portfolio
    • 12.7.4. Strategic Initiatives
  • 12.8. AstraZeneca PLC
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Portfolio
    • 12.8.4. Strategic Initiatives
  • 12.9. Ironwood Pharmaceuticals Inc.
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Portfolio
    • 12.9.4. Strategic Initiatives
  • 12.10. Bausch Health Companies Inc.
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Portfolio
    • 12.10.4. Strategic Initiatives
  • 12.11. GlaxoSmithKline, Plc.
    • 12.11.1. Company Overview
    • 12.11.2. Financial Performance
    • 12.11.3. Product Portfolio
    • 12.11.4. Strategic Initiatives
  • 12.12. Lexicon Pharmaceuticals, Inc.
    • 12.12.1. Company Overview
    • 12.12.2. Financial Performance
    • 12.12.3. Product Portfolio
    • 12.12.4. Strategic Initiatives
  • 12.13. Sucampo Pharmaceuticals, Inc.
    • 12.13.1. Company Overview
    • 12.13.2. Financial Performance
    • 12.13.3. Product Portfolio
    • 12.13.4. Strategic Initiatives
  • 12.14. Other Notable Players
    • 12.14.1. Company Overview
    • 12.14.2. Financial Performance
    • 12.14.3. Product Portfolio
    • 12.14.4. Strategic Initiatives

List of Tables

  • TABLE 1 Global Irritable Bowel Syndrome Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 2 Global Irritable Bowel Syndrome Treatment Market By IBS-C, 2021-2031, USD (Million)

TABLE 3 Global Irritable Bowel Syndrome Treatment Market By IBS-D, 2021-2031, USD (Million)

TABLE 4 Global Irritable Bowel Syndrome Treatment Market By Product, 2021-2031, USD (Million)

  • TABLE 5 North America Irritable Bowel Syndrome Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 6 North America Irritable Bowel Syndrome Treatment Market By IBS-C, 2021-2031, USD (Million)

TABLE 7 North America Irritable Bowel Syndrome Treatment Market By IBS-D, 2021-2031, USD (Million)

TABLE 8 North America Irritable Bowel Syndrome Treatment Market By Product, 2021-2031, USD (Million)

  • TABLE 9 U.S. Irritable Bowel Syndrome Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 10 U.S. Irritable Bowel Syndrome Treatment Market By IBS-C, 2021-2031, USD (Million)

TABLE 11 U.S. Irritable Bowel Syndrome Treatment Market By IBS-D, 2021-2031, USD (Million)

TABLE 12 U.S. Irritable Bowel Syndrome Treatment Market By Product, 2021-2031, USD (Million)

  • TABLE 13 Canada Irritable Bowel Syndrome Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 14 Canada Irritable Bowel Syndrome Treatment Market By IBS-C, 2021-2031, USD (Million)

TABLE 15 Canada Irritable Bowel Syndrome Treatment Market By IBS-D, 2021-2031, USD (Million)

TABLE 16 Canada Irritable Bowel Syndrome Treatment Market By Product, 2021-2031, USD (Million)

  • TABLE 17 Rest of North America Irritable Bowel Syndrome Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 18 Rest of North America Irritable Bowel Syndrome Treatment Market By IBS-C, 2021-2031, USD (Million)

TABLE 19 Rest of North America Irritable Bowel Syndrome Treatment Market By IBS-D, 2021-2031, USD (Million)

TABLE 20 Rest of North America Irritable Bowel Syndrome Treatment Market By Product, 2021-2031, USD (Million)

  • TABLE 21 UK and European Union Irritable Bowel Syndrome Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 22 UK and European Union Irritable Bowel Syndrome Treatment Market By IBS-C, 2021-2031, USD (Million)

TABLE 23 UK and European Union Irritable Bowel Syndrome Treatment Market By IBS-D, 2021-2031, USD (Million)

TABLE 24 UK and European Union Irritable Bowel Syndrome Treatment Market By Product, 2021-2031, USD (Million)

  • TABLE 25 UK Irritable Bowel Syndrome Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 26 UK Irritable Bowel Syndrome Treatment Market By IBS-C, 2021-2031, USD (Million)

TABLE 27 UK Irritable Bowel Syndrome Treatment Market By IBS-D, 2021-2031, USD (Million)

TABLE 28 UK Irritable Bowel Syndrome Treatment Market By Product, 2021-2031, USD (Million)

  • TABLE 29 Germany Irritable Bowel Syndrome Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 30 Germany Irritable Bowel Syndrome Treatment Market By IBS-C, 2021-2031, USD (Million)

TABLE 31 Germany Irritable Bowel Syndrome Treatment Market By IBS-D, 2021-2031, USD (Million)

TABLE 32 Germany Irritable Bowel Syndrome Treatment Market By Product, 2021-2031, USD (Million)

  • TABLE 33 Spain Irritable Bowel Syndrome Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 34 Spain Irritable Bowel Syndrome Treatment Market By IBS-C, 2021-2031, USD (Million)

TABLE 35 Spain Irritable Bowel Syndrome Treatment Market By IBS-D, 2021-2031, USD (Million)

TABLE 36 Spain Irritable Bowel Syndrome Treatment Market By Product, 2021-2031, USD (Million)

  • TABLE 37 Italy Irritable Bowel Syndrome Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 38 Italy Irritable Bowel Syndrome Treatment Market By IBS-C, 2021-2031, USD (Million)

TABLE 39 Italy Irritable Bowel Syndrome Treatment Market By IBS-D, 2021-2031, USD (Million)

TABLE 40 Italy Irritable Bowel Syndrome Treatment Market By Product, 2021-2031, USD (Million)

  • TABLE 41 France Irritable Bowel Syndrome Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 42 France Irritable Bowel Syndrome Treatment Market By IBS-C, 2021-2031, USD (Million)

TABLE 43 France Irritable Bowel Syndrome Treatment Market By IBS-D, 2021-2031, USD (Million)

TABLE 44 France Irritable Bowel Syndrome Treatment Market By Product, 2021-2031, USD (Million)

  • TABLE 45 Rest of Europe Irritable Bowel Syndrome Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 46 Rest of Europe Irritable Bowel Syndrome Treatment Market By IBS-C, 2021-2031, USD (Million)

TABLE 47 Rest of Europe Irritable Bowel Syndrome Treatment Market By IBS-D, 2021-2031, USD (Million)

TABLE 48 Rest of Europe Irritable Bowel Syndrome Treatment Market By Product, 2021-2031, USD (Million)

  • TABLE 49 Asia Irritable Bowel Syndrome Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 50 Asia Irritable Bowel Syndrome Treatment Market By IBS-C, 2021-2031, USD (Million)

TABLE 51 Asia Irritable Bowel Syndrome Treatment Market By IBS-D, 2021-2031, USD (Million)

TABLE 52 Asia Irritable Bowel Syndrome Treatment Market By Product, 2021-2031, USD (Million)

  • TABLE 53 China Irritable Bowel Syndrome Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 54 China Irritable Bowel Syndrome Treatment Market By IBS-C, 2021-2031, USD (Million)

TABLE 55 China Irritable Bowel Syndrome Treatment Market By IBS-D, 2021-2031, USD (Million)

TABLE 56 China Irritable Bowel Syndrome Treatment Market By Product, 2021-2031, USD (Million)

  • TABLE 57 Japan Irritable Bowel Syndrome Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 58 Japan Irritable Bowel Syndrome Treatment Market By IBS-C, 2021-2031, USD (Million)

TABLE 59 Japan Irritable Bowel Syndrome Treatment Market By IBS-D, 2021-2031, USD (Million)

TABLE 60 Japan Irritable Bowel Syndrome Treatment Market By Product, 2021-2031, USD (Million)

  • TABLE 61 India Irritable Bowel Syndrome Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 62 India Irritable Bowel Syndrome Treatment Market By IBS-C, 2021-2031, USD (Million)

TABLE 63 India Irritable Bowel Syndrome Treatment Market By IBS-D, 2021-2031, USD (Million)

TABLE 64 India Irritable Bowel Syndrome Treatment Market By Product, 2021-2031, USD (Million)

  • TABLE 65 Australia Irritable Bowel Syndrome Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 66 Australia Irritable Bowel Syndrome Treatment Market By IBS-C, 2021-2031, USD (Million)

TABLE 67 Australia Irritable Bowel Syndrome Treatment Market By IBS-D, 2021-2031, USD (Million)

TABLE 68 Australia Irritable Bowel Syndrome Treatment Market By Product, 2021-2031, USD (Million)

  • TABLE 69 South Korea Irritable Bowel Syndrome Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 70 South Korea Irritable Bowel Syndrome Treatment Market By IBS-C, 2021-2031, USD (Million)

TABLE 71 South Korea Irritable Bowel Syndrome Treatment Market By IBS-D, 2021-2031, USD (Million)

TABLE 72 South Korea Irritable Bowel Syndrome Treatment Market By Product, 2021-2031, USD (Million)

  • TABLE 73 Latin America Irritable Bowel Syndrome Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 74 Latin America Irritable Bowel Syndrome Treatment Market By IBS-C, 2021-2031, USD (Million)

TABLE 75 Latin America Irritable Bowel Syndrome Treatment Market By IBS-D, 2021-2031, USD (Million)

TABLE 76 Latin America Irritable Bowel Syndrome Treatment Market By Product, 2021-2031, USD (Million)

  • TABLE 77 Brazil Irritable Bowel Syndrome Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 78 Brazil Irritable Bowel Syndrome Treatment Market By IBS-C, 2021-2031, USD (Million)

TABLE 79 Brazil Irritable Bowel Syndrome Treatment Market By IBS-D, 2021-2031, USD (Million)

TABLE 80 Brazil Irritable Bowel Syndrome Treatment Market By Product, 2021-2031, USD (Million)

  • TABLE 81 Mexico Irritable Bowel Syndrome Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 82 Mexico Irritable Bowel Syndrome Treatment Market By IBS-C, 2021-2031, USD (Million)

TABLE 83 Mexico Irritable Bowel Syndrome Treatment Market By IBS-D, 2021-2031, USD (Million)

TABLE 84 Mexico Irritable Bowel Syndrome Treatment Market By Product, 2021-2031, USD (Million)

  • TABLE 85 Rest of Latin America Irritable Bowel Syndrome Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 86 Rest of Latin America Irritable Bowel Syndrome Treatment Market By IBS-C, 2021-2031, USD (Million)

TABLE 87 Rest of Latin America Irritable Bowel Syndrome Treatment Market By IBS-D, 2021-2031, USD (Million)

TABLE 88 Rest of Latin America Irritable Bowel Syndrome Treatment Market By Product, 2021-2031, USD (Million)

  • TABLE 89 Middle East and Africa Irritable Bowel Syndrome Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 90 Middle East and Africa Irritable Bowel Syndrome Treatment Market By IBS-C, 2021-2031, USD (Million)

TABLE 91 Middle East and Africa Irritable Bowel Syndrome Treatment Market By IBS-D, 2021-2031, USD (Million)

TABLE 92 Middle East and Africa Irritable Bowel Syndrome Treatment Market By Product, 2021-2031, USD (Million)

  • TABLE 93 GCC Irritable Bowel Syndrome Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 94 GCC Irritable Bowel Syndrome Treatment Market By IBS-C, 2021-2031, USD (Million)

TABLE 95 GCC Irritable Bowel Syndrome Treatment Market By IBS-D, 2021-2031, USD (Million)

TABLE 96 GCC Irritable Bowel Syndrome Treatment Market By Product, 2021-2031, USD (Million)

  • TABLE 97 Africa Irritable Bowel Syndrome Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 98 Africa Irritable Bowel Syndrome Treatment Market By IBS-C, 2021-2031, USD (Million)

TABLE 99 Africa Irritable Bowel Syndrome Treatment Market By IBS-D, 2021-2031, USD (Million)

TABLE 100 Africa Irritable Bowel Syndrome Treatment Market By Product, 2021-2031, USD (Million)

  • TABLE 101 Rest of Middle East and Africa Irritable Bowel Syndrome Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 102 Rest of Middle East and Africa Irritable Bowel Syndrome Treatment Market By IBS-C, 2021-2031, USD (Million)

TABLE 103 Rest of Middle East and Africa Irritable Bowel Syndrome Treatment Market By IBS-D, 2021-2031, USD (Million)

TABLE 104 Rest of Middle East and Africa Irritable Bowel Syndrome Treatment Market By Product, 2021-2031, USD (Million)

List of Figures

  • FIG. 1 Global Irritable Bowel Syndrome Treatment Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Irritable Bowel Syndrome Treatment Market: Quality Assurance
  • FIG. 5 Global Irritable Bowel Syndrome Treatment Market, By Type, 2022
  • FIG. 6 Global Irritable Bowel Syndrome Treatment Market, By Product, 2022
  • FIG. 7 Global Irritable Bowel Syndrome Treatment Market, By Geography, 2022
  • FIG. 8 Market Geographical Opportunity Matrix - Global Irritable Bowel Syndrome Treatment Market, 2022

FIG. 9Market Positioning of Key Irritable Bowel Syndrome Treatment Market Players, 2022

FIG. 10Global Irritable Bowel Syndrome Treatment Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031

  • FIG. 11 Global Irritable Bowel Syndrome Treatment Market, By Type, 2022 Vs 2031, %
  • FIG. 12 Global Irritable Bowel Syndrome Treatment Market, By Product, 2022 Vs 2031, %
  • FIG. 13 U.S. Irritable Bowel Syndrome Treatment Market (US$ Million), 2021 - 2031
  • FIG. 14 Canada Irritable Bowel Syndrome Treatment Market (US$ Million), 2021 - 2031
  • FIG. 15 Rest of North America Irritable Bowel Syndrome Treatment Market (US$ Million), 2021 - 2031
  • FIG. 16 UK Irritable Bowel Syndrome Treatment Market (US$ Million), 2021 - 2031
  • FIG. 17 Germany Irritable Bowel Syndrome Treatment Market (US$ Million), 2021 - 2031
  • FIG. 18 Spain Irritable Bowel Syndrome Treatment Market (US$ Million), 2021 - 2031
  • FIG. 19 Italy Irritable Bowel Syndrome Treatment Market (US$ Million), 2021 - 2031
  • FIG. 20 France Irritable Bowel Syndrome Treatment Market (US$ Million), 2021 - 2031
  • FIG. 21 Rest of Europe Irritable Bowel Syndrome Treatment Market (US$ Million), 2021 - 2031
  • FIG. 22 China Irritable Bowel Syndrome Treatment Market (US$ Million), 2021 - 2031
  • FIG. 23 Japan Irritable Bowel Syndrome Treatment Market (US$ Million), 2021 - 2031
  • FIG. 24 India Irritable Bowel Syndrome Treatment Market (US$ Million), 2021 - 2031
  • FIG. 25 Australia Irritable Bowel Syndrome Treatment Market (US$ Million), 2021 - 2031
  • FIG. 26 South Korea Irritable Bowel Syndrome Treatment Market (US$ Million), 2021 - 2031
  • FIG. 27 Rest of Asia Irritable Bowel Syndrome Treatment Market (US$ Million), 2021 - 2031
  • FIG. 28 Brazil Irritable Bowel Syndrome Treatment Market (US$ Million), 2021 - 2031
  • FIG. 29 Mexico Irritable Bowel Syndrome Treatment Market (US$ Million), 2021 - 2031
  • FIG. 30 Rest of Latin America Irritable Bowel Syndrome Treatment Market (US$ Million), 2021 - 2031
  • FIG. 31 GCC Irritable Bowel Syndrome Treatment Market (US$ Million), 2021 - 2031
  • FIG. 32 Africa Irritable Bowel Syndrome Treatment Market (US$ Million), 2021 - 2031
  • FIG. 33 Rest of Middle East and Africa Irritable Bowel Syndrome Treatment Market (US$ Million), 2021 - 2031